[Allergic rhinitis and bronchial asthma. Stepwise plans for the treatment].
Bischoff
Angelika
A
D000485:Allergens; D031164:Ambrosia / Q000276:immunology; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D008137:Longitudinal Studies; D000069444:Omalizumab; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000276:immunology; D012307:Risk Factors; D001620:beta-Thromboglobulin
D000485:Allergens; D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001620:beta-Thromboglobulin; D000069444:Omalizumab